phenol has been researched along with Giant Cell Tumor of Bone in 16 studies
Giant Cell Tumor of Bone: A bone tumor composed of cellular spindle-cell stroma containing scattered multinucleated giant cells resembling osteoclasts. The tumors range from benign to frankly malignant lesions. The tumor occurs most frequently in an end of a long tubular bone in young adults. (From Dorland, 27th ed; Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The rate of recurrence of giant cell tumor of bone is decreased by use of adjuvant treatments such as phenol, liquid nitrogen, or polymethylmethacrylate (PMMA) during curettage." | 7.80 | Liquid nitrogen or phenolization for giant cell tumor of bone?: a comparative cohort study of various standard treatments at two tertiary referral centers. ( Dijkstra, PD; Schreuder, HW; van de Sande, MA; van der Geest, IC; van der Heijden, L, 2014) |
| "The rate of recurrence of giant cell tumor of bone is decreased by use of adjuvant treatments such as phenol, liquid nitrogen, or polymethylmethacrylate (PMMA) during curettage." | 3.80 | Liquid nitrogen or phenolization for giant cell tumor of bone?: a comparative cohort study of various standard treatments at two tertiary referral centers. ( Dijkstra, PD; Schreuder, HW; van de Sande, MA; van der Geest, IC; van der Heijden, L, 2014) |
| "Phenol is a commonly used adjuvant associated with local control rates ranging from 9% to 25%." | 1.37 | Similar local control between phenol- and ethanol-treated giant cell tumors of bone. ( Chen, CY; Lan, TY; Lin, WH; Wu, K; Yang, RS, 2011) |
| "Phenolization is an effective and safe local adjuvant therapy for GCT." | 1.30 | Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone. ( Baur, A; Dürr, HR; Jansson, V; Maier, M; Refior, HJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Oshiro, H | 1 |
| Tome, Y | 1 |
| Tsuha, Y | 1 |
| Aoki, Y | 1 |
| Mizuta, K | 1 |
| Nishida, K | 1 |
| Bickels, J | 1 |
| Campanacci, DA | 1 |
| Takeuchi, A | 1 |
| Suwanpramote, P | 1 |
| Yamamoto, N | 1 |
| Shirai, T | 1 |
| Hayashi, K | 1 |
| Kimura, H | 1 |
| Miwa, S | 1 |
| Higuchi, T | 1 |
| Abe, K | 1 |
| Tsuchiya, H | 1 |
| Moon, MS | 1 |
| Kim, SS | 2 |
| Moon, JL | 1 |
| Moon, H | 1 |
| van der Heijden, L | 2 |
| van der Geest, IC | 1 |
| Schreuder, HW | 1 |
| van de Sande, MA | 2 |
| Dijkstra, PD | 2 |
| Lackman, RD | 1 |
| Crawford, EA | 1 |
| King, JJ | 1 |
| Ogilvie, CM | 1 |
| Gortzak, Y | 1 |
| Kandel, R | 1 |
| Deheshi, B | 1 |
| Werier, J | 1 |
| Turcotte, RE | 1 |
| Ferguson, PC | 1 |
| Wunder, JS | 1 |
| Lin, WH | 1 |
| Lan, TY | 1 |
| Chen, CY | 1 |
| Wu, K | 1 |
| Yang, RS | 1 |
| Tejwani, SG | 1 |
| Hame, SL | 1 |
| Eckardt, JJ | 1 |
| Lim, YW | 1 |
| Tan, MH | 1 |
| Becker, WT | 1 |
| Dohle, J | 1 |
| Bernd, L | 1 |
| Braun, A | 1 |
| Cserhati, M | 1 |
| Enderle, A | 1 |
| Hovy, L | 1 |
| Matejovsky, Z | 1 |
| Szendroi, M | 1 |
| Trieb, K | 2 |
| Tunn, PU | 1 |
| Pingsmann, A | 1 |
| Müller, RT | 2 |
| Quint, U | 1 |
| Müller, G | 1 |
| Dürr, HR | 1 |
| Maier, M | 1 |
| Jansson, V | 1 |
| Baur, A | 1 |
| Refior, HJ | 1 |
| Bitzan, P | 1 |
| Lang, S | 1 |
| Dominkus, M | 1 |
| Kotz, R | 1 |
1 review available for phenol and Giant Cell Tumor of Bone
| Article | Year |
|---|---|
Local Adjuvant Substances Following Curettage of Bone Tumors.
Topics: Anti-Infective Agents, Local; Antineoplastic Combined Chemotherapy Protocols; Argon Plasma Coagulati | 2020 |
15 other studies available for phenol and Giant Cell Tumor of Bone
| Article | Year |
|---|---|
Packing with alpha-tricalcium phosphate followed by curettage and phenol-ethanol ablation for appendicular giant cell tumor of bone.
Topics: Bone Neoplasms; Curettage; Ethanol; Giant Cell Tumor of Bone; Humans; Neoplasm Recurrence, Local; Os | 2022 |
Mid- to long-term clinical outcome of giant cell tumor of bone treated with calcium phosphate cement following thorough curettage and phenolization.
Topics: Adult; Bone Cements; Bone Neoplasms; Calcium Phosphates; Curettage; Female; Follow-Up Studies; Giant | 2018 |
Treating giant cell tumours with curettage, electrocautery, burring, phenol irrigation, and cementation.
Topics: Administration, Topical; Adult; Bone Neoplasms; Cementation; Combined Modality Therapy; Curettage; E | 2013 |
Liquid nitrogen or phenolization for giant cell tumor of bone?: a comparative cohort study of various standard treatments at two tertiary referral centers.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Bone Transplantation; Child; Cohort Studies; Curettage; Fem | 2014 |
Conservative treatment of Campanacci grade III proximal humerus giant cell tumors.
Topics: Adolescent; Adult; Bone Neoplasms; Bone Transplantation; Curettage; Feasibility Studies; Female; Gia | 2009 |
The efficacy of chemical adjuvants on giant-cell tumour of bone. An in vitro study.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Survival; Chemotherapy, Adjuvant; Chlorides; DNA, Neopla | 2010 |
Similar local control between phenol- and ethanol-treated giant cell tumors of bone.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Ethanol; Giant Cell Tumor of Bone; Hu | 2011 |
Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.
Topics: Adolescent; Adult; Aged; Bone Cements; Bone Neoplasms; Cohort Studies; Combined Modality Therapy; Co | 2012 |
Subchondral giant-cell tumor of the proximal tibia: arthroscopic treatment for accelerated articular cartilage and meniscal degeneration in two patients.
Topics: Adult; Arthroscopy; Bone Cements; Bone Neoplasms; Cartilage, Articular; Cautery; Combined Modality T | 2004 |
Treatment of benign giant cell tumours of bone in Singapore.
Topics: Adult; Bone Neoplasms; Combined Modality Therapy; Cryotherapy; Disease-Free Survival; Female; Giant | 2005 |
Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
Topics: Antineoplastic Agents; Bone Cements; Bone Neoplasms; Cautery; Combined Modality Therapy; Curettage; | 2008 |
[Process and outcome quality in giant cell tumor in relation to surgical management].
Topics: Adult; Bone Cements; Bone Neoplasms; Combined Modality Therapy; Cryosurgery; Female; Giant Cell Tumo | 1997 |
Characteristics of phenol. Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma.
Topics: Adult; Bone Neoplasms; Chondroblastoma; Chondroma; Combined Modality Therapy; Female; Giant Cell Tum | 1998 |
Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Child; Disease Progression; Giant Ce | 1999 |
Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Bone Transplantation; Chemotherapy, Adjuvant; Child; Curett | 2001 |